Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention
Author(s) -
Takekuni Hayashi,
Seiji Fukamizu,
Rintaro Hojo,
Kota Komiyama,
Yasuhiro Tanabe,
Tamotsu Tejima,
Kyoko Soejima,
Mitsuhiro Nishizaki,
Masayasu Hiraoka,
Junya Ako,
Shinichi Momomura,
Harumizu Sakurada
Publication year - 2013
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eut050
Subject(s) - medicine , implantable cardioverter defibrillator , ventricular tachycardia , incidence (geometry) , catheter ablation , primary prevention , cardiology , cardiomyopathy , heart disease , tachycardia , shock (circulatory) , ablation , hypertrophic cardiomyopathy , surgery , heart failure , disease , physics , optics
Prophylactic catheter ablation (CA) has been established to reduce the incidence of appropriate implantable cardioverter-defibrillator (ICD) therapy (anti-tachycardia pacing or shock) in secondary prevention patients. The aim of this study was to determine whether prophylactic CA for induced ventricular tachycardia (VT) reduces the incidence of appropriate ICD therapy in primary prevention patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom